The Asia Pacific Anastomosis Devices Market is expected to witness market growth of 7.2% CAGR during the forecast period (2022-2028).
Custom robotic deposition equipment was used to create easy-to-use silk-based resorbable as well as suture-less anastomosis devices. Retention strength, crush resistance, and leak resistance were all high in silk-based heparin-eluting devices. These devices were put to the test in a porcine implant, where they stayed intact. Histological research revealed that the implant wall was degrading and absorbing, indicating that cells were able to enter into the lamellar section of the device, indicating the possibility of tissue regeneration.
Anastomotic devices technology is rapidly advancing. The next generation of these devices, for both distal as well as proximal anastomoses, is expected to be easier to load and deploy, and can enable anastomoses to be built in any order. The ability to instrument the graft solely through the piece that will be discarded, rather of the portion that will stay to act as a conduit, reduces the risk of endothelial injury, allowing more widespread usage of these devices with arterial conduits. With the advancement of these technologies, it can be able to perform multivessel CABG without cardiopulmonary bypass in less than half of the time and with much less morbidity.
The APAC Market is being majorly dominated by growing economies such as Japan, China, and India. Because of better economic conditions, rising healthcare awareness, and an ageing population in this region, the requirement for surgeries across this region is estimated to surge over the forecasting years. Because older people are more prone to gastrointestinal and cardiovascular problems, there is expected to be an increase in the number of people requiring surgeries.
Obesity rates are rising at an alarming rate, particularly in urban areas. Between 1975 and 2016, the global prevalence of obesity nearly tripled. 30-65 percent of the adult urban population is overweight or obese. When compared to the rural population, the BMI of urban Indians is higher. The abdominal obesity, rather than the increased BMI, is a cause for concern. Men in urban areas have a waist-to-hip ratio of 0.99, whereas men in rural areas have a waist-to-hip ratio of 0.95. Obesity in the abdomen is also more common than obesity in general.
The China Market dominated the Asia Pacific Anastomosis Devices Market by Country 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $411 million by 2028. The Japan Market is experiencing a CAGR of 6.6% during (2022-2028). Additionally, The India Market is expected to exhibit a CAGR of 7.9% during (2022-2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
By Product Type
By Country
Custom robotic deposition equipment was used to create easy-to-use silk-based resorbable as well as suture-less anastomosis devices. Retention strength, crush resistance, and leak resistance were all high in silk-based heparin-eluting devices. These devices were put to the test in a porcine implant, where they stayed intact. Histological research revealed that the implant wall was degrading and absorbing, indicating that cells were able to enter into the lamellar section of the device, indicating the possibility of tissue regeneration.
Anastomotic devices technology is rapidly advancing. The next generation of these devices, for both distal as well as proximal anastomoses, is expected to be easier to load and deploy, and can enable anastomoses to be built in any order. The ability to instrument the graft solely through the piece that will be discarded, rather of the portion that will stay to act as a conduit, reduces the risk of endothelial injury, allowing more widespread usage of these devices with arterial conduits. With the advancement of these technologies, it can be able to perform multivessel CABG without cardiopulmonary bypass in less than half of the time and with much less morbidity.
The APAC Market is being majorly dominated by growing economies such as Japan, China, and India. Because of better economic conditions, rising healthcare awareness, and an ageing population in this region, the requirement for surgeries across this region is estimated to surge over the forecasting years. Because older people are more prone to gastrointestinal and cardiovascular problems, there is expected to be an increase in the number of people requiring surgeries.
Obesity rates are rising at an alarming rate, particularly in urban areas. Between 1975 and 2016, the global prevalence of obesity nearly tripled. 30-65 percent of the adult urban population is overweight or obese. When compared to the rural population, the BMI of urban Indians is higher. The abdominal obesity, rather than the increased BMI, is a cause for concern. Men in urban areas have a waist-to-hip ratio of 0.99, whereas men in rural areas have a waist-to-hip ratio of 0.95. Obesity in the abdomen is also more common than obesity in general.
The China Market dominated the Asia Pacific Anastomosis Devices Market by Country 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $411 million by 2028. The Japan Market is experiencing a CAGR of 6.6% during (2022-2028). Additionally, The India Market is expected to exhibit a CAGR of 7.9% during (2022-2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Disposable and
- Reusable
- Cardiovascular Surgery
- Gastrointestinal Surgery and
- Others
- Hospitals and
- Ambulatory Care Centers & Clinics
By Country
- China12:08 03/06/2022
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- LivaNova PLC
- Becton, Dickinson and Company
- Johnson & Johnson
- Peters Surgical
- Smith & Nephew PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- ConMed Corporation
- Baxter International, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Asia Pacific Anastomosis Devices Market by Product Type
Chapter 4. Asia Pacific Anastomosis Devices Market by Application
Chapter 5. Asia Pacific Anastomosis Devices Market by End User
Chapter 6. Asia Pacific Anastomosis Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Medtronic PLC
- LivaNova PLC
- Becton, Dickinson and Company
- Johnson & Johnson
- Peters Surgical
- Smith & Nephew PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- ConMed Corporation
- Baxter International, Inc.
Methodology
LOADING...
